Download FREE Report Sample
Download Free sampleNivolumab Injection is suitable for treating adult patients with locally advanced or metastatic non-small cell lung cancer (NSCLC) who are negative for mutations in the epidermal growth factor receptor (EGFR) gene and negative for anaplastic lymphoma kinase (ALK), who have previously undergone platinum-containing chemotherapy and whose disease has progressed or is intolerable.
Nivolumab Injection Market contains market size and forecasts of Nivolumab Injection in global, including the following market information:
Global Nivolumab Injection Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global Nivolumab Injection Market Sales, 2017-2022, 2023-2028, (K Units)
Global top five Nivolumab Injection companies in 2021 (%)
The global Nivolumab Injection market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
100IU Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Nivolumab Injection include AbbVie, Allergan, Ono Pharmaceutical, Sinopharm and Bristol-Myers Squibb, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
We surveyed the Nivolumab Injection manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Nivolumab Injection Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global Nivolumab Injection Market Segment Percentages, by Type, 2021 (%)
100IU
50IU
Other
Global Nivolumab Injection Market, by Application, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global Nivolumab Injection Market Segment Percentages, by Application, 2021 (%)
Unresectable Melanoma
Metastatic Melanoma
Metastatic Squamous NSCLC
Classical Hodgkin Lymphoma
Renal Cell Carcinoma
Other
Global Nivolumab Injection Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global Nivolumab Injection Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Nivolumab Injection revenues in global market, 2017-2022 (Estimated), ($ millions)
Key companies Nivolumab Injection revenues share in global market, 2021 (%)
Key companies Nivolumab Injection sales in global market, 2017-2022 (Estimated), (K Units)
Key companies Nivolumab Injection sales share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
AbbVie
Allergan
Ono Pharmaceutical
Sinopharm
Bristol-Myers Squibb
Speak to our Custom Research Team and get the Custom Research in a budget
Custom ResearchFrequently Asked Questions ?
A license granted to one user. Rules or conditions might be applied for e.g. the use of electric files (PDFs) or printings, depending on product.
A license granted to multiple users.
A license granted to a single business site/establishment.
A license granted to all employees within organisation access to the product.
Upto Working 24 to 48 hrs
Upto 72 hrs max - Weekends and Public Holidays
Online Payments with PayPal and CCavenue
Wire Transfer/Bank Transfer
Hard Copy
Industry Market SizeSWOT AnalysisIndustry Major PlayersRevenue ForecastsHistorical and Forecast GrowthProfitability Analysis
